Medication info

Albekem Tablets

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Baskhan Bio Pharmaceutical Co., Ltd.
Appearance
Green round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201904508 · Approved 2019.07.02

This product's status changed to Expired on 2024.07.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (e.g., ulcers, gastritis, and Zollinger-Ellison syndrome); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, without regard to meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent the development of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs generally heal within 4 weeks, and ulcers generally heal within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is preferable to also administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Baskhan Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (e.g., ulcers, gastritis, and Zollinger-Ellison syndrome); prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcers
View approved original text

This medication is used to treat gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also aids in the prevention of post-surgical ulcers and the treatment of gastric and duodenal ulcers caused by NSAID consumption. It is sometimes administered before anesthesia to prevent Mendelson's syndrome. It is effective in improving various gastrointestinal disorders.

How to take

Adult dose

○ Adults Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, without regard to meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent the development of gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs generally heal within 4 weeks, and ulcers generally heal within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is preferable to also administer 2 tablets on the night before surgery.

Precautions

This medication should not be administered to patients with poor kidney function or those undergoing dialysis. Patients who have had allergic reactions to this drug or its components should also avoid it. Patients with a history of acute porphyria should not be given this drug, as it may exacerbate symptoms. Patients who have undergone gastrointestinal surgery or those who need to limit potassium intake should not use this medication for safety. It should not be given to pregnant women or those who may become pregnant, nor to premature infants or newborns. Patients with liver dysfunction or a history of drug allergies should use this medication cautiously, and elderly patients and those with a history of kidney disease need to be careful. If taking non-steroidal anti-inflammatory drugs (NSAIDs) together, especially elderly individuals or those with a history of peptic ulcers should undergo regular monitoring during treatment. Because it may mask symptoms of stomach cancer, patients with gastric ulcers or those over middle age with new or changed symptoms of dyspepsia should verify the absence of malignant diseases before use. Patients with Helicobacter pylori infection and gastric or duodenal ulcers should receive concomitant treatment to eradicate the bacteria. Use in severe critical care patients may lead to gastric stones, and caution is needed for patients with hypophosphatemia as the aluminum component of this drug may interfere with phosphate absorption. Care should be taken for patients who have difficulty swallowing as there is a risk of respiratory complications. Rarely, shock or severe allergic reactions may occur when taking this medication, so if symptoms appear, treatment should be stopped immediately and medical assistance sought. Allergic symptoms may include skin rash, urticaria, angioedema, fever, and bronchospasm, and all medications should be discontinued if such symptoms develop. Abnormalities may appear in blood tests, and if symptoms such as fatigue, bleeding, or fever arise, immediate testing and necessary measures should be taken. If symptoms of liver dysfunction occur, the medication should be discontinued immediately, as cardiac-related abnormalities such as arrhythmia or vasculitis have also been reported rarely. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, and stool color may change, although this does not require treatment. Severe cases, particularly in the elderly, may exhibit neurological symptoms such as dizziness, drowsiness, confusion, seizures, insomnia, headaches, anxiety, etc., so careful observation is required. Musculoskeletal symptoms such as myalgia or arthralgia may also occur rarely, and in severe cases, discontinuation of the medication is required. Symptoms such as skin itching, hair loss, or stomatitis may also occur. Avoid long-term use, and if no therapeutic effect is observed, switch to another medication while regularly testing blood, liver, and kidney functions. Elderly or chronically ill patients may have an increased risk of pneumonia, requiring caution. If dizziness or drowsiness occurs while taking this medication, avoid driving or operating hazardous machinery. There may be interactions with other medications, so inform your doctor or pharmacist of any medications being taken, as some may require dosage adjustments or discontinuation when taken with this medication. It is safest for women who are pregnant or breastfeeding to avoid taking this medication. Safety in children has not been established, so it is recommended not to administer this medication to children. In case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and blood dialysis may be performed if needed. This medication may reduce gastric acid secretion and promote bacterial growth within the gastrointestinal tract, so ophthalmic examinations may be needed with long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 48 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • bone marrow suppression
  • aplastic anemia
  • refractory anemia
  • acquired hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous and mucosal bleeding
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • feeling of heaviness in the head
  • illness feelings
  • anxiety
  • mental confusion
  • depression
  • hallucination
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • myoclonus
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • stomatitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure, and the storage temperature should be maintained between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Green round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.